Helius Medical Technologies Net Income
| HSDT Stock | USD 2.21 0.28 14.51% |
As of the 15th of February 2026, Helius Medical retains the Standard Deviation of 7.07, risk adjusted performance of (0.12), and Market Risk Adjusted Performance of (0.51). Helius Medical technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices.
Helius Medical Total Revenue |
|
Gross Profit | Market Capitalization | Enterprise Value Revenue 95.8556 | Revenue | Earnings Share (829.83) |
| Last Reported | Projected for Next Year | ||
| Net Loss | -10.6 M | -11.1 M | |
| Net Loss | -10.6 M | -11.1 M | |
| Net Loss | -12.7 M | -13.3 M | |
| Net Loss | (3.90) | (4.09) |
Helius | Net Income | Build AI portfolio with Helius Stock |
The evolution of Net Income for Helius Medical Technologies provides essential context for understanding the company's financial health trajectory. By analyzing this metric's behavior over time, investors can assess whether recent trends align with long-term patterns, and how Helius Medical compares to historical norms and industry peers.
Latest Helius Medical's Net Income Growth Pattern
Below is the plot of the Net Income of Helius Medical Technologies over the last few years. Net income is one of the most important fundamental items in finance. It plays a large role in Helius Medical Techn financial statement analysis. It represents the amount of money remaining after all of Helius Medical Technologies operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. It is Helius Medical's Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Helius Medical's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported (11.74 M) | 10 Years Trend |
|
Net Income |
| Timeline |
Helius Net Income Regression Statistics
| Arithmetic Mean | (12,072,986) | |
| Coefficient Of Variation | (58.94) | |
| Mean Deviation | 5,013,655 | |
| Median | (9,838,317) | |
| Standard Deviation | 7,115,914 | |
| Sample Variance | 50.6T | |
| Range | 27.6M | |
| R-Value | (0.24) | |
| Mean Square Error | 50.8T | |
| R-Squared | 0.06 | |
| Significance | 0.35 | |
| Slope | (343,563) | |
| Total Sum of Squares | 810.2T |
Helius Net Income History
Other Fundumenentals of Helius Medical Techn
| Net Income From Continuing Ops | ||
| Net Income Applicable To Common Shares | ||
| Net Income Per Share | ||
| Net Income Per E B T |
Helius Net Income Driver Correlations
Understanding the fundamental principles of building solid financial models for Helius Medical is extremely important. It helps to project a fair market value of Helius Stock properly, considering its historical fundamentals such as Net Income. Since Helius Medical's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Helius Medical's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Helius Medical's interrelated accounts and indicators.
Click cells to compare fundamentals
Is there potential for Health Care Equipment & Supplies market expansion? Will Helius introduce new products? Factors like these will boost the valuation of Helius Medical. Market participants price Helius higher when confident in its future expansion prospects. Understanding fair value requires weighing current performance against future potential. All the valuation information about Helius Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (829.83) | Revenue Per Share | Quarterly Revenue Growth 12.667 | Return On Assets | Return On Equity |
Understanding Helius Medical Techn requires distinguishing between market price and book value, where the latter reflects Helius's accounting equity. The concept of intrinsic value - what Helius Medical's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Market sentiment, economic cycles, and investor behavior can push Helius Medical's price substantially above or below its fundamental value.
Please note, there is a significant difference between Helius Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Helius Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. In contrast, Helius Medical's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.
Helius Medical 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Helius Medical's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Helius Medical.
| 11/17/2025 |
| 02/15/2026 |
If you would invest 0.00 in Helius Medical on November 17, 2025 and sell it all today you would earn a total of 0.00 from holding Helius Medical Technologies or generate 0.0% return on investment in Helius Medical over 90 days. Helius Medical is related to or competes with Nano X, Inogen, Electromed, Perspective Therapeutics, Outset Medical, SANUWAVE Health,, and Profound Medical. Helius Medical Technologies, Inc., a neurotechnology company, focuses on developing, licensing, and acquiring non-invasi... More
Helius Medical Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Helius Medical's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Helius Medical Technologies upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.16) | |||
| Maximum Drawdown | 29.52 | |||
| Value At Risk | (10.79) | |||
| Potential Upside | 13.03 |
Helius Medical Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Helius Medical's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Helius Medical's standard deviation. In reality, there are many statistical measures that can use Helius Medical historical prices to predict the future Helius Medical's volatility.| Risk Adjusted Performance | (0.12) | |||
| Jensen Alpha | (1.23) | |||
| Total Risk Alpha | (1.63) | |||
| Treynor Ratio | (0.52) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Helius Medical's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Helius Medical February 15, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.12) | |||
| Market Risk Adjusted Performance | (0.51) | |||
| Mean Deviation | 5.7 | |||
| Coefficient Of Variation | (645.55) | |||
| Standard Deviation | 7.07 | |||
| Variance | 49.97 | |||
| Information Ratio | (0.16) | |||
| Jensen Alpha | (1.23) | |||
| Total Risk Alpha | (1.63) | |||
| Treynor Ratio | (0.52) | |||
| Maximum Drawdown | 29.52 | |||
| Value At Risk | (10.79) | |||
| Potential Upside | 13.03 | |||
| Skewness | 0.5291 | |||
| Kurtosis | (0.25) |
Helius Medical Techn Backtested Returns
Helius Medical Techn holds Efficiency (Sharpe) Ratio of -0.11, which attests that the entity had a -0.11 % return per unit of risk over the last 3 months. Helius Medical Techn exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check out Helius Medical's Market Risk Adjusted Performance of (0.51), risk adjusted performance of (0.12), and Standard Deviation of 7.07 to validate the risk estimate we provide. The company retains a Market Volatility (i.e., Beta) of 2.13, which attests to a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Helius Medical will likely underperform. At this point, Helius Medical Techn has a negative expected return of -0.82%. Please make sure to check out Helius Medical's potential upside, as well as the relationship between the rate of daily change and period momentum indicator , to decide if Helius Medical Techn performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.85 |
Very good predictability
Helius Medical Technologies has very good predictability. Overlapping area represents the amount of predictability between Helius Medical time series from 17th of November 2025 to 1st of January 2026 and 1st of January 2026 to 15th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Helius Medical Techn price movement. The serial correlation of 0.85 indicates that around 85.0% of current Helius Medical price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.85 | |
| Spearman Rank Test | 0.72 | |
| Residual Average | 0.0 | |
| Price Variance | 0.28 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Helius Accumulated Other Comprehensive Income
Accumulated Other Comprehensive Income |
|
Based on the recorded statements, Helius Medical Technologies reported net income of (11.74 Million). This is 103.44% lower than that of the Health Care Equipment & Supplies sector and 104.93% lower than that of the Health Care industry. The net income for all United States stocks is 102.06% higher than that of the company.
Helius Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Helius Medical's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Helius Medical could also be used in its relative valuation, which is a method of valuing Helius Medical by comparing valuation metrics of similar companies.Helius Medical is currently under evaluation in net income category among its peers.
Helius Medical ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Helius Medical's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Helius Medical's managers, analysts, and investors.Environmental | Governance | Social |
Helius Medical Institutional Holders
Institutional Holdings refers to the ownership stake in Helius Medical that is held by large financial organizations, pension funds or endowments. Institutions may hold large blocks of Helius Medical's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Helius Medical's value.| Shares | Sbi Securities Co Ltd | 2025-06-30 | 46.0 | Ubs Group Ag | 2025-03-31 | 0.0 | Corecap Advisors, Llc | 2025-06-30 | 13.0 | Grant Private Wealth Management Inc | 2025-06-30 | 0.0 | Federation Des Caisses Desjardins Du Quebec | 2025-03-31 | 0.0 | Virtu Financial Llc | 2025-03-31 | 0.0 | Advisor Group Holdings, Inc. | 2025-03-31 | 0.0 | Fedenia Advisers Llc | 2025-03-31 | 0.0 | St Germain D J Co Inc | 2025-06-30 | 0.0 | Two Sigma Securities, Llc | 2025-03-31 | 0.0 | Citigroup Inc | 2025-03-31 | 0.0 |
Helius Fundamentals
| Return On Equity | -3.44 | ||||
| Return On Asset | -0.0399 | ||||
| Operating Margin | (7.04) % | ||||
| Current Valuation | 90.2 M | ||||
| Shares Outstanding | 41.3 M | ||||
| Shares Owned By Insiders | 25.67 % | ||||
| Shares Owned By Institutions | 33.05 % | ||||
| Number Of Shares Shorted | 1.35 M | ||||
| Price To Earning | (13.85) X | ||||
| Price To Book | 109.75 X | ||||
| Price To Sales | 97.00 X | ||||
| Revenue | 520 K | ||||
| Gross Profit | 467 K | ||||
| EBITDA | (13.8 M) | ||||
| Net Income | (11.74 M) | ||||
| Cash And Equivalents | 3.27 M | ||||
| Cash Per Share | 0.12 X | ||||
| Total Debt | 12 K | ||||
| Debt To Equity | 0.03 % | ||||
| Current Ratio | 2.85 X | ||||
| Book Value Per Share | (3.78) X | ||||
| Cash Flow From Operations | (11.04 M) | ||||
| Short Ratio | 3.11 X | ||||
| Earnings Per Share | (829.83) X | ||||
| Target Price | 4.0 | ||||
| Number Of Employees | 21 | ||||
| Beta | 1.05 | ||||
| Market Capitalization | 91.28 M | ||||
| Total Asset | 3.54 M | ||||
| Retained Earnings | (171.7 M) | ||||
| Working Capital | 1.26 M | ||||
| Current Asset | 6.8 M | ||||
| Current Liabilities | 4.46 M | ||||
| Net Asset | 3.54 M |
About Helius Medical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Helius Medical Technologies's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Helius Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Helius Medical Technologies based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Helius Stock Analysis
When running Helius Medical's price analysis, check to measure Helius Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Helius Medical is operating at the current time. Most of Helius Medical's value examination focuses on studying past and present price action to predict the probability of Helius Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Helius Medical's price. Additionally, you may evaluate how the addition of Helius Medical to your portfolios can decrease your overall portfolio volatility.